KRMD
insider transactionsKORU Medical Systems, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 30d
+12.5K
12.5K buy · 0 sell
Net value · 30d
$49.3K
$49.3K in · $0 out
Sentiment · 30d
Net buying
100% buying · 0% selling
Open-market trades · 30d
2
12.5K buy · 0 sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Buy·P
President-Chief Commercial Off
$29.5K
7.5K sh · $3.93
Own +2%
-
Buy·P
President-Chief Commercial Off
$19.8K
5.0K sh · $3.96
Own +2%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 11, 2026 | Adam R Kalbermatten KEY | Buy P | 7.5K | $29.5K |
| Jun 11, 2026 | Adam R Kalbermatten KEY | Buy P | 5.0K | $19.8K |
About KRMD insider trading
This page tracks insider transactions for KORU Medical Systems, Inc. (KRMD) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.